Abbott Laboratories (ABT) is priced at $117.32 after the most recent trading session. At the very opening of the session, the stock price was $117.90 and reached a high price of $118.31, prior to closing the session it reached the value of $116.88. The stock touched a low price of $116.41.Recently in News on September 30, 2021, Abbott Commits to Reducing Malnutrition Globally With Launch of Abbott Center for Malnutrition Solutions. Abbott is investing $45 million annually to help identify, treat and prevent malnutrition. You can read further details here
Abbott Laboratories had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $129.70 on 09/13/21, with the lowest value was $105.36 for the same time period, recorded on 06/02/21.
Abbott Laboratories (ABT) full year performance was 5.65%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Abbott Laboratories shares are logging -9.54% during the 52-week period from high price, and 13.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $103.13 and $129.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4545205 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Abbott Laboratories (ABT) recorded performance in the market was 7.15%, having the revenues showcasing 0.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 207.14B, as it employees total of 109000 workers.
Market experts do have their say about Abbott Laboratories (ABT)
During the last month, 15 analysts gave the Abbott Laboratories a BUY rating, 4 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 119.37, with a change in the price was noted -0.48. In a similar fashion, Abbott Laboratories posted a movement of -0.41% for the period of last 100 days, recording 5,619,799 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABT is recording 0.55 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.52.
Technical breakdown of Abbott Laboratories (ABT)
Raw Stochastic average of Abbott Laboratories in the period of last 50 days is set at 19.09%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 21.19%. In the last 20 days, the company’s Stochastic %K was 21.76% and its Stochastic %D was recorded 21.66%.
Bearing in mind the latest performance of Abbott Laboratories, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 7.15%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -3.44%, alongside a boost of 5.65% for the period of the last 12 months. The shares increased approximately by 1.24% in the 7-day charts and went up by -7.34% in the period of the last 30 days. Common stock shares were driven by 0.13% during last recorded quarter.